Skip to main content
TipRanks
Go Ultimate75% OFF

Global X Genomics & Biotechnology UCITS ETF (DE:GN0M) Price & Chart

DE:GN0M ETF Chart & Stats

€10.39
At close: 4:00 PM EST
€9€10€11Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
EUR 10.39 - EUR 10.75
52-Week Range
EUR 6.44 - EUR 11.74
Previous Close
EUR 10.64
Volume
44.26K
Average Volume (3M)
38.85K
AUM
145.76M
NAV
11.61
Expense Ratio
0.50%
Holdings Count
51
Beta
0.78
Inception Date
Nov 02, 2021
Last Dividend Ex-Date
N/A
Dividend Yield
N/A
Shares Outstanding
11,780,000
Standard Deviation
N/A

ETF Overview

Global X Genomics & Biotechnology UCITS ETF

The Global X Genomics & Biotechnology UCITS ETF, trading under the ticker DE:GN0M, offers investors a dynamic opportunity to delve into the cutting-edge world of genomic advancements. As a sector-focused ETF, it specifically targets the burgeoning niche of genomics and biotechnology, positioning itself at the forefront of medical innovation and technological development. This fund is meticulously designed to capture the growth potential of companies that are revolutionizing healthcare through genetic research, biotechnological breakthroughs, and the development of novel therapies. By investing in DE:GN0M, stakeholders gain exposure to a diversified portfolio of industry leaders and pioneering firms that are driving the future of medicine and personalized healthcare. This ETF not only reflects the transformative impact of genomic sciences but also aligns with the growing demand for thematic investment strategies focused on sectors poised for substantial long-term growth.

DE:GN0M ETF News

DE:GN0M ETF FAQ

What was DE:GN0M’s price range in the past 12 months?
DE:GN0M’s lowest price in the past 12 months was EUR 6.44 and its highest was EUR 11.74.
What is the AUM of DE:GN0M?
As of Nov 10, 2026, the AUM of DE:GN0M is €145.76M.
Is DE:GN0M overvalued?
Based on Wall Street analyst price targets for DE:GN0M’s holdings, DE:GN0M’s price is currently undervalued.
How many shares outstanding does DE:GN0M have?
DE:GN0M has 11,780,000 shares outstanding.